Product Information
METOPROLOL SUCC ER 100 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.0822 per EA under NDC 68001035800. Its NADAC has been published 370 times since Jan 2, 2019.
FDA first approved this application on Feb 6, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Metoprolol Succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001035800
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA204106FDA Approved
2/6/2018
TE Code
AB
On Market Since
6/29/2018
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 100 MG TAB has been published 370 times since Jan 2, 2019, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0822 per EA |
|---|---|
| All-time high | $0.2769 (Jul 10, 2019) |
| All-time low | $0.0822 (Feb 18, 2026) |
| 52-week high | $0.0998 |
| 52-week low | $0.0822 |
| Median price | $0.1497 |
| Average price | $0.1608 |
| Largest weekly change | +47.2% (Mar 20, 2024) |
| Weeks tracked | 370 |
| Tracking since | Jan 2, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-17.6%
3Y
-41.7%
5Y
-53.5%
All
-69.8%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 100 MG TAB, manufactured by BluePoint Laboratories, is $0.0822 per EA (NDC 68001035800), effective Feb 18, 2026.
How has the price of METOPROLOL SUCC ER 100 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 100 MG TAB has declined 69.8%. It has been tracked across 370 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 100 MG TAB?
Since Jan 2, 2019, the NADAC for METOPROLOL SUCC ER 100 MG TAB has ranged from a low of $0.0822 (Feb 18, 2026) to a high of $0.2769 (Jul 10, 2019), with a median of $0.1497 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 100 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL SUCC ER 100 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METOPROLOL SUCC ER 100 MG TAB?
METOPROLOL SUCC ER 100 MG TAB (NDC 68001035800) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.